Osteosarcoma of the Extremities with Synchronous Lung Metastases: Long-Term Results in 44 Patients Treated with Neoadjuvant Chemotherapy
Authors:
- A. BriccoliABA. Briccoli
- M. MercuriMMM. Mercuri
- S. FerrariSFS. Ferrari
- F. BertoniFBF. Bertoni
- A. GasbarriniA. Gasbarrini
- N. FabbriNFN. Fabbri
- M. CesariMCM. Cesari
- C. ForniCFC. Forni
- M. CampanacciMCM. Campanacci
- 1 January 1998
- journal article
- clinical trial
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 10 (1) , 69-76
Abstract
Between September 1986 and September 1991, 44 patients with lung metastases originating from an osteosarcoma of an extremity were treated with: primary chemotherapy, simultaneous resection of primary and metastatic lesions (when feasible), and then further chemotherapy. After primary chemotherapy, lung metastases disappeared in 5 patients, whereas in 11 patients they remained surgically unresectable. All 16 patients received local treatment of the primary tumor only. In the remaining 28 patients simultaneous surgical treatment of the primary and the metastatic tumor was performed. The removal of metastatic lesions was complete in 25 and incomplete in 3 patients. With a median follow-up of 8 years (5.5-10.8) all 14 patients who never achieved a tumor-free status died. Of the 30 patients who achieved remission 5 (17%) remained continuously free of disease and 25 developed new metastases, associated with local recurrence in 4 cases. The 5-year overall survival for all 44 patients of the study was 14%, and the 5-year disease-free survival for the 30 patients who reached remission was 17%. These results are significantly worse than those achieved with the same chemotherapy protocol in 144 contemporary patients with localized disease at presentation (73% disease-free and 79% overall survival). We conclude that, despite aggressive chemotherapy which is successful in patients with localized disease, the prognosis remains very poor for patients with osteosarcoma of the extremities with lung metastases at presentation, and justifies the use of novel therapies.Keywords
This publication has 13 references indexed in Scilit:
- Osteogenic sarcoma with clinically detectable metastasis at initial presentation.Journal of Clinical Oncology, 1993
- Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosisCancer, 1992
- Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.Journal of Clinical Oncology, 1992
- Results of multiple pulmonary resections for metastatic osteogenic sarcoma after two decadesJournal of Surgical Oncology, 1991
- Median sternotomy and multiple lung resections for metastatic sarcomasEuropean Journal of Cardio-Thoracic Surgery, 1990
- Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized studyEuropean Journal of Cancer and Clinical Oncology, 1986
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Pulmonary metastases from osteogenic sarcoma: Complete resection and effective chemotherapy contributing to improved prognosisEuropean Paediatric Haematology and Oncology, 1985
- Survival Following Aggressive Resection of Pulmonary Metastases from Osteogenic Sarcoma: Analysis of Prognostic FactorsThe Annals of Thoracic Surgery, 1983
- Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgeryCancer, 1979